Latest filing published 06 Feb 2026 for Syndax Pharmaceuticals Inc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Pierre Legault span 2 companies, the busiest being Syndax Pharmaceuticals Inc and BICYCLE THERAPEUTICS plc. Between 20 December 2021 and 4 February 2026, the trades on record add up to 13 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 6 February 2026: a share grant, in Syndax Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations